An Extension Study of EV-BR1701 Part A1
Clinical trial NCT07635966 · COMPLETED
Trial details
- NCT number
- NCT07635966
- Sponsor
- Enimmune Corporation
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-20
- Primary completion
- 2025-12-27
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.